Alessandra Martignoni
About
In The Last Decade
Alessandra Martignoni
12 papers receiving 214 citations
Peers
Comparison fields: 5 of 47
- Immunology 107
- Rheumatology 86
- Cardiology and Cardiovascular Medicine 65
- Biochemistry 62
- Endocrinology, Diabetes and Metabolism 31
Countries citing papers authored by Alessandra Martignoni
This map shows the geographic impact of Alessandra Martignoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Martignoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Martignoni more than expected).
Fields of papers citing papers by Alessandra Martignoni
This network shows the impact of papers produced by Alessandra Martignoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Martignoni. The network helps show where Alessandra Martignoni may publish in the future.
Co-authorship network of co-authors of Alessandra Martignoni
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Martignoni. A scholar is included among the top collaborators of Alessandra Martignoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Martignoni. Alessandra Martignoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | [Management of stroke in a ward of internal medicine. Limits and prospects]. | 1 |
| 5 | 86 | |
| 6 | 8 | |
| 7 | Carotid intima-media thickening and in vivo LDL oxidation in patients with essential hypertension. | 8 |
| 8 | 66 | |
| 9 | [Autoantibodies against oxidised low density lipoproteins in patients with coronary disease]. | 21 |
| 10 | 8 | |
| 11 | Ipercolesterolemia e parametri emoreologici. | 0 |
| 12 | High-density lipoprotein cholesterol increase in hypertensive patients treated with the calcium channel blocker tiapamil | 1 |
| 13 | Effects of nisoldipine treatment on plasma lipoproteins | 4 |
| 14 | Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril. | 11 |
| 15 | Effect of mepindolol on serum lipids. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.